Team:MIT/Project

From 2013.igem.org

(Difference between revisions)
 
(25 intermediate revisions not shown)
Line 1: Line 1:
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
{{MIT-results2}}
-
!align="center"|[[Team:MIT|Home]]
+
<html>
-
!align="center"|[[Team:MIT/Team|Team]]
+
<head>
-
!align="center"|[https://igem.org/Team.cgi?year=2013&team_name=MIT Official Team Profile]
+
<script>
-
!align="center"|[[Team:MIT/Project|Project]]
+
document.title = "MIT iGEM - Circuit Production";
-
!align="center"|[[Team:MIT/Parts|Parts Submitted to the Registry]]
+
$(document).ready(function() {
-
!align="center"|[[Team:MIT/Modeling|Modeling]]
+
    $("#accordion").accordion("option", "animated", false);
-
!align="center"|[[Team:MIT/Notebook|Notebook]]
+
    $("#accordion").accordion("activate", 0);
-
!align="center"|[[Team:MIT/Safety|Safety]]
+
    $("#accordion").accordion("option", "animated", 'slide');
-
!align="center"|[[Team:MIT/Attributions|Attributions]]
+
});
-
|}
+
</script>
 +
</head>
 +
<body>
 +
<div id="col_left">
-
== '''Overall project''' ==
+
<p>
 +
<div style="text-align:justify">
 +
<h1>The Roadmap to Exosomal Cell-Cell Communication</h1>
 +
The MIT iGEM team sought to create a new mode of engineered intercellular communication for use in synthetic biology by modifying the contents of existing exosomes through the use of naturally occurring miRNA and the protein domain Acyl-TyA. We built on existing research targeting proteins to exosomes to enable intercellular communication by targeting signal proteins into exosomes and into HEK 293 receiver cells.<br><br>
-
While pharmaceutical companies rely on many model systems for the development and testing of candidates, these systems often are not predictive of actual efficacy and toxicity in patients.  An ideal system for drug development would recapitulate in vivo responses in a scalable fashion.
+
Over the summer, we accomplished the following: <br><br>
-
One promising approach is the creation of engineered tissues via genetic reprogramming. A cell programmed with a synthetic gene network could multiply and give rise to synthetic tissues comprised of multiple cell types. While there has been some success in engineering genetic circuits within mammalian cells, most of these circuits function in single cells independent of the global population. The formation of predictable complex structures and engineered multicellular tissues requires coordinated behavior among populations of cells.  
+
<h3>(1) Exosomal Cell-Cell Communication with miRNA</h3>
 +
Jurkat T cells are known to produce a large number of exosomes which naturally contain high levels of miRNA 451. Using this natural system, our initial goal is to create a miRNA 451/Exosome sensor to begin our work with Exosomal communication.<br><br>
-
== Project Details==
+
<h3>(2) Creating/Testing miRNA Sensor</h3>
 +
We constructed an EYFP fluorescent gene with four miRNA 451 target sites which will allow the EYFP reporter to be repressed by the miRNA 451. By expressing our reporter along with synthetic siRNA 451, we saw repression of our reporter.<br><br>
-
This year, the MIT iGEM team is working to develop circuits that implement multiplexed cell-cell communication mediated by exosomes in mammalian cells. Our approach is to incorporate two parallel signaling strategies using exosomes: small miRNA and a Cas9 complex.
+
<h3>(3) Exosomes + Sensor</h3>
 +
After seeing our sensor work with siRNA 451, we then isolated exosomes from Jurkat T cells and used them to treat HEK 293 expressing our reporter. We observed similar repression of our reporter.<br><br>
-
=== miRNA Signaling ===
+
<h3>(4) Jurkat T Cells + Sensor</h3>
 +
With our reporter sensing isolated exosomes, we proceeded to coculture both Jurkat T cells producing exosomes with HEK 293 cells transfected with our reporter. We observed repression of our reporter indicating that we have achieved CELL-CELL COMMUNICATION!<br><br>
-
In the first strategy, we utilize miRNA that are selectively targeted into exosomes. Sender cells produce exosomes with our miRNA signals. These exosomes carry signals to engineered receiver cells that use these miRNA inputs to modulate gene expression.  
+
<h3>(5) Exosomal Cell-Cell Communication with Proteins</h3>
 +
Proteins have been shown to be targeted into exosomes with the addition of a high-order oligomerizing protein Acyl-TyA. By fusing a protein signal to an Acyl-TyA domain, we could send the protein from cell to cell through exosomes.  
 +
<br><br>
-
==== The Experiments ====
+
<h3>(6) Protein Targeting</h3>
 +
We began by fusing Acyl-TyA to GFP and observing colocalization of the Acyl-TyA-GFP with the membrane stain Rh-PE, which has been shown to be targeted to the site of exosomal biogenesis. Then, we demonstrated through a western blot that our protein signal exists within the exosome rich media.<br><br>
-
=== Protein Signaling===
+
<h3>(7) Testing our Protein Signal</h3>
 +
We demonstrated retained functionality of our protein signal after fusion with Acyl-TyA (Acyl-TyA-rtTA3). In addition, we tested our reporter construct (TRE-tight_mkate), which allowed us to assay for the function of our protein signal.<br><br>
-
The second signaling strategy employs proteins contained within exosomes. We fuse targeting motifs to a CAS9-VP16 protein resulting in selective exosomal partitioning of this species in sender cells. In receiver cells, this signal modulates gene expression through the Cas9-CRISPR mechanism with a variable guide RNA.  
+
<h3>(8) Application - Endogenous Gene Activation</h3>
 +
Most regulated promoters in Synthetic Biology have been engineered to have upstream regulatory sites, but endogenous genes don't have such features. Activating an endogenous gene would require targeting an activator to an arbitrary sequence upstream of an endogenous promoter. Cas9 allows us to target arbitrary sequences using a guide RNA specific to that sequence. By fusing a VP16 domain to Cas9 we're able to create a programmable DNA binding trans-activator.<br><br>
-
==== The Experiments ====
+
<h3>(9) Testing Cas9-VP16</h3>
 +
We tested our Cas9-VP16 fusion protein by transfecting it into HEK 293 cells along with a guide RNA which will target the Cas9-VP16 to upstream regulatory sites on our reporter construct and activate the expression of EYFP. We showed that our Cas9-VP16 fusion is indeed functional. <br><br>
-
== Results ==
+
<h3>(10) Future Work</h3>
 +
We currently have being constructed an Acyl-TyA-Cas9-VP16 fusion protein to send through exosomes to activate endogenous genes within receiver cells.<br><br>
-
== Applications ==
 
-
Successful completion of our project would enable a localized, controllable system to induce changes in cellular surroundings for use in pharmaceutical research. Our populations would function as engineered tissues or ‘organoids’ for rapid screening and development of drugs.
+
</div> <!--End col_left-->
-
 
+
</body>
-
Additionally, because the Cas9-CRISPR mechanism does not require engineered receiver cells, this may enable a new strategy for gene therapy and cell re-programming.
+
</html>

Latest revision as of 03:57, 29 October 2013

iGEM 2012

Overview

  • Project Overview

miRNA Signal

  • Overview
  • siRNA Characterization
  • Exosome Isolation and Co-Culturing
  • Cell-Cell Co-Culturing

Protein Signals

  • Overview
  • GFP
  • rtTA3
  • Cre
  • L7Ae
  • Cas9-VP16

Novel DNA Sensor: Cas9 Split Venus Fusion

  • Overview
  • Leucine Zipper Fusion
  • DNA Sensing

Our BioBricks

  • Favorites
  • All BioBricks

Attributions

  • Attributions

The Roadmap to Exosomal Cell-Cell Communication

The MIT iGEM team sought to create a new mode of engineered intercellular communication for use in synthetic biology by modifying the contents of existing exosomes through the use of naturally occurring miRNA and the protein domain Acyl-TyA. We built on existing research targeting proteins to exosomes to enable intercellular communication by targeting signal proteins into exosomes and into HEK 293 receiver cells.

Over the summer, we accomplished the following:

(1) Exosomal Cell-Cell Communication with miRNA

Jurkat T cells are known to produce a large number of exosomes which naturally contain high levels of miRNA 451. Using this natural system, our initial goal is to create a miRNA 451/Exosome sensor to begin our work with Exosomal communication.

(2) Creating/Testing miRNA Sensor

We constructed an EYFP fluorescent gene with four miRNA 451 target sites which will allow the EYFP reporter to be repressed by the miRNA 451. By expressing our reporter along with synthetic siRNA 451, we saw repression of our reporter.

(3) Exosomes + Sensor

After seeing our sensor work with siRNA 451, we then isolated exosomes from Jurkat T cells and used them to treat HEK 293 expressing our reporter. We observed similar repression of our reporter.

(4) Jurkat T Cells + Sensor

With our reporter sensing isolated exosomes, we proceeded to coculture both Jurkat T cells producing exosomes with HEK 293 cells transfected with our reporter. We observed repression of our reporter indicating that we have achieved CELL-CELL COMMUNICATION!

(5) Exosomal Cell-Cell Communication with Proteins

Proteins have been shown to be targeted into exosomes with the addition of a high-order oligomerizing protein Acyl-TyA. By fusing a protein signal to an Acyl-TyA domain, we could send the protein from cell to cell through exosomes.

(6) Protein Targeting

We began by fusing Acyl-TyA to GFP and observing colocalization of the Acyl-TyA-GFP with the membrane stain Rh-PE, which has been shown to be targeted to the site of exosomal biogenesis. Then, we demonstrated through a western blot that our protein signal exists within the exosome rich media.

(7) Testing our Protein Signal

We demonstrated retained functionality of our protein signal after fusion with Acyl-TyA (Acyl-TyA-rtTA3). In addition, we tested our reporter construct (TRE-tight_mkate), which allowed us to assay for the function of our protein signal.

(8) Application - Endogenous Gene Activation

Most regulated promoters in Synthetic Biology have been engineered to have upstream regulatory sites, but endogenous genes don't have such features. Activating an endogenous gene would require targeting an activator to an arbitrary sequence upstream of an endogenous promoter. Cas9 allows us to target arbitrary sequences using a guide RNA specific to that sequence. By fusing a VP16 domain to Cas9 we're able to create a programmable DNA binding trans-activator.

(9) Testing Cas9-VP16

We tested our Cas9-VP16 fusion protein by transfecting it into HEK 293 cells along with a guide RNA which will target the Cas9-VP16 to upstream regulatory sites on our reporter construct and activate the expression of EYFP. We showed that our Cas9-VP16 fusion is indeed functional.

(10) Future Work

We currently have being constructed an Acyl-TyA-Cas9-VP16 fusion protein to send through exosomes to activate endogenous genes within receiver cells.